Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goff

Showing results (11-20 of 625) with videos related to

Pageof 63
Sort By:
The Journal of Clinical Psychiatry|November 1, 1986
The stimulant challenge test in depressionD C Goff
The American Journal of Psychiatry|March 1, 2026
With No Surprises From the EMERGENT-4 Trial, Where Do We Go From Here?Donald C Goff
Journal of Clinical Psychopharmacology|February 6, 2025
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)Donald C Goff
The American Journal of Psychiatry|September 2, 2015
Brexpiprazole: A New Antipsychotic Following in the Footsteps of AripiprazoleDonald C Goff
The American Journal of Psychiatry|February 2, 2018
Optimizing the Pharmacologic Treatment of Individuals With First-Episode PsychosisDonald C Goff
JAMA|December 28, 2020
The Pharmacologic Treatment of Schizophrenia-2021Donald C Goff
JAMA|May 22, 2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with newDonald C Goff
The American Journal of Psychiatry|December 1, 1985
Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitorD C Goff
Harvard Review of Psychiatry|July 1, 1995
Have the serotonin-dopamine antagonists rendered traditional antipsychotic agents obsolete?D C Goff
The Journal of Clinical Psychiatry|August 19, 2007
Integrating general health care in private community psychiatry practiceDonald C Goff
Pageof 63

Showing results (11-20 of 625) with videos related to

Sort By:
Pageof 63
The Journal of Clinical Psychiatry|November 1, 1986
The stimulant challenge test in depressionD C Goff
The American Journal of Psychiatry|March 1, 2026
With No Surprises From the EMERGENT-4 Trial, Where Do We Go From Here?Donald C Goff
Journal of Clinical Psychopharmacology|February 6, 2025
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)Donald C Goff
The American Journal of Psychiatry|September 2, 2015
Brexpiprazole: A New Antipsychotic Following in the Footsteps of AripiprazoleDonald C Goff
The American Journal of Psychiatry|February 2, 2018
Optimizing the Pharmacologic Treatment of Individuals With First-Episode PsychosisDonald C Goff
JAMA|December 28, 2020
The Pharmacologic Treatment of Schizophrenia-2021Donald C Goff
JAMA|May 22, 2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with newDonald C Goff
The American Journal of Psychiatry|December 1, 1985
Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitorD C Goff
Harvard Review of Psychiatry|July 1, 1995
Have the serotonin-dopamine antagonists rendered traditional antipsychotic agents obsolete?D C Goff
The Journal of Clinical Psychiatry|August 19, 2007
Integrating general health care in private community psychiatry practiceDonald C Goff
Pageof 63